GlassScriptPhysician profile
Samuel D Schenker
NPI 1750327326
$830.07
in general payments reported to CMS, 2019-2025
11 companies · $23.35 in 2025
The $23.35 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2021: $107 · 2022: $116 · 2023: $15.49 · 2024: $91.50 · 2025: $23.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $139.30 | 2019-2023 | Vraylar |
| Amgen INC. | $124.98 | 2019 | |
| Spr Therapeutics, INC | $116.16 | 2022 | |
| Celgene Corporation | $110.39 | 2019 | |
| Royal Biologics, INC. | $91.50 | 2024 | |
| Novartis Pharmaceuticals Corporation | $90.98 | 2019 | |
| Stryker Corporation | $86.39 | 2021 | |
| Merz North America, INC. | $23.35 | 2025 | |
| Arbor Pharmaceuticals, INC. | $20.58 | 2021 | |
| Indivior INC. | $14.29 | 2019 | |
| Scilex Pharmaceuticals INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Schenker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.